Bessemer Group Portfolio holdings
AUM
$61.6B
1-Year Return
25.88%
This Quarter Return
-12.49%
1 Year Return
+25.88%
3 Year Return
+112.29%
5 Year Return
+188.53%
10 Year Return
+439.25%
AUM
$23B
AUM Growth
-$3.9B
(-15%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
19.56%
Holding
2,169
New
348
Increased
820
Reduced
439
Closed
204
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$379M |
| 2 |
Vanguard Extended Market ETF
VXF
|
$284M |
| 3 |
CME Group
CME
|
$239M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$228M |
| 5 |
Vanguard Total World Stock ETF
VT
|
$218M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$227M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$215M |
| 3 |
Johnson & Johnson
JNJ
|
$197M |
| 4 |
Altria Group
MO
|
$177M |
| 5 |
Qualcomm
QCOM
|
$174M |
Sector Composition
| 1 | Financials | 14.54% |
| 2 | Technology | 14.2% |
| 3 | Healthcare | 13.45% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Vanguard Large-Cap ETF
VV
$44.6B
| $807K | ﹤0.01% |
7,027
+882
| +14% | +$101K |
|
|
WMC
627
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $806K | ﹤0.01% |
9,660
+4,170
| +76% | +$348K |
|
628
ResMed
RMD
$40.6B
| $798K | ﹤0.01% |
7,015
+4,843
| +223% | +$551K |
|
629
PTC
PTC
$25.6B
| $796K | ﹤0.01% |
9,604
+9,566
| +25,174% | +$793K |
|
630
iShares MSCI Japan ETF
EWJ
$15.5B
| $790K | ﹤0.01% |
15,575
-405,750
| -96% | -$20.6M |
|
631
Integra LifeSciences
IART
$1.25B
| $789K | ﹤0.01% |
17,500
-16,200
| -48% | -$730K |
|
632
Antero Resources
AR
$10.1B
| $784K | ﹤0.01% |
83,523
| – | – |
|
|
OXFD
633
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $778K | ﹤0.01% |
+60,900
| New | +$778K |
|
634
ANI Pharmaceuticals
ANIP
$2.07B
| $774K | ﹤0.01% |
17,200
+14,764
| +606% | +$664K |
|
635
Interface
TILE
$1.64B
| $774K | ﹤0.01% |
54,300
-11,100
| -17% | -$158K |
|
636
Goldman Sachs
GS
$223B
| $771K | ﹤0.01% |
4,615
-229
| -5% | -$38.3K |
|
637
Innoviva
INVA
$1.29B
| $767K | ﹤0.01% |
43,919
+42,681
| +3,448% | +$745K |
|
638
Hawkins
HWKN
$3.49B
| $753K | ﹤0.01% |
36,800
+13,600
| +59% | +$278K |
|
639
Trimble
TRMB
$19.2B
| $749K | ﹤0.01% |
22,782
+8,176
| +56% | +$269K |
|
640
Sysco
SYY
$39.4B
| $744K | ﹤0.01% |
11,886
-76,218
| -87% | -$4.77M |
|
641
GSK
GSK
$81.5B
| $743K | ﹤0.01% |
15,569
+332
| +2% | +$15.8K |
|
642
TruBridge
TBRG
$300M
| $738K | ﹤0.01% |
29,400
+6,800
| +30% | +$171K |
|
|
ZIXI
643
DELISTED
Zix Corporation
ZIXI
| $737K | ﹤0.01% |
128,600
+49,800
| +63% | +$285K |
|
644
Toro Company
TTC
$7.99B
| $731K | ﹤0.01% |
13,069
+4,026
| +45% | +$225K |
|
645
Utah Medical Products
UTMD
$203M
| $731K | ﹤0.01% |
8,800
+1,500
| +21% | +$125K |
|
646
Stryker
SYK
$150B
| $730K | ﹤0.01% |
4,663
+1,174
| +34% | +$184K |
|
|
TAST
647
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $726K | ﹤0.01% |
73,740
+43,740
| +146% | +$431K |
|
648
MetLife
MET
$52.9B
| $725K | ﹤0.01% |
17,666
+3,577
| +25% | +$147K |
|
649
Vanguard Russell 1000 Growth ETF
VONG
$31.1B
| $722K | ﹤0.01% |
+21,464
| New | +$722K |
|
650
LeMaitre Vascular
LMAT
$2.21B
| $721K | ﹤0.01% |
30,500
+9,500
| +45% | +$225K |
|